{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:32:57Z","timestamp":1790789577378,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      The aim of this study was to assess the performance of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-DOTATOC PET\/CT in the detection and extension of insulinomas according to 3 different contexts: sporadic benign, sporadic metastatic, and multiple endocrine neoplasia type 1 (MEN1).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      The data of 71 adult patients who underwent\n                      <jats:sup>68<\/jats:sup>\n                      Ga-DOTATOC PET\/CT for suspected or confirmed sporadic insulinoma, suspicion of insulinoma in the context of MEN1, follow-up of metastatic insulinoma, or suspicion of recurrence of insulinoma were retrospectively analyzed. Pathological examination or strong clinical and biological findings were used as standards of truth.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For the assessment of a confirmed sporadic insulinoma in 17 patients, the sensitivity of SR-PET was 75%, including 2 patients for whom metastatic lesions had been revealed by SR-PET. For 35 patients with a suspicion of insulinoma, the sensitivity was 39%. In 10 patients followed up for metastatic insulinoma, the sensitivity was 100%. For 5 patients with a history of MEN1, interpretation of SR-PET was difficult, as 3 of them presented with multiple pancreatic uptake foci. The global sensitivity of SR-PET in all insulinomas excluding those with a MEN1 story was 64% (100% for metastatic insulinomas, 62% for benign insulinomas), with a specificity of 89%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      Ga-DOTATOC PET\/CT is a useful examination tool for the assessment of insulinomas in selected contexts, with very high performance for the detection and extension workup of metastatic insulinomas and high specificity for the detection of sporadic benign insulinomas. The examination should be completed with GLP-1 receptor PET when it is negative or in a MEN1 context.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004126","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T03:01:17Z","timestamp":1647831677000},"page":"394-401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Role of 68Ga-DOTATOC PET\/CT in Insulinoma According to 3 Different Contexts: A Retrospective Study"],"prefix":"10.1097","volume":"47","author":[{"given":"Pierre-Louis","family":"Moreau","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Tenon AP-HP and Sorbonne University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Aveline","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Tenon AP-HP and Sorbonne University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Maitre","sequence":"additional","affiliation":[{"name":"Endocrinology, H\u00f4pital Saint-Antoine AP-HP and Sorbonne University, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[{"name":"Endocrinology, H\u00f4pital Bic\u00eatre AP-HP and University Paris Sud, Le Kremlin-Bic\u00eatre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dubreuil","sequence":"additional","affiliation":[{"name":"Department of Digestive Oncology, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timofei","family":"Rusu","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Tenon AP-HP and Sorbonne University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Montravers","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Tenon AP-HP and Sorbonne University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0025-6196(12)62083-7","article-title":"Functioning insulinoma\u2014incidence, recurrence, and long-term survival of patients: a 60-year study","volume":"66","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2005.06.002","article-title":"Endocrine tumours of the pancreas","volume":"19","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10552-010-9512-y","article-title":"Incidence rates of exocrine and endocrine pancreatic cancers in the United States","volume":"21","year":"2010","journal-title":"Cancer Causes Control"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jss.2003.12.007","article-title":"Pancreatic endocrine tumors","volume":"120","year":"2004","journal-title":"J Surg Res"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ando.2013.05.006","article-title":"Insulinoma of genetic aetiology","volume":"74","year":"2013","journal-title":"Ann Endocrinol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jcem.85.11.6934","article-title":"The prolonged fast","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2174\/0929867043365026","article-title":"Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders","volume":"11","year":"2004","journal-title":"Curr Med Chem"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.lpm.2013.08.007","article-title":"Recommandations pour la prise en charge de l'insulinome malin [Malignant insulinoma: recommendations for workup and treatment]","volume":"43","year":"2014","journal-title":"Presse Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.crad.2005.06.005","article-title":"Multimodality preoperative imaging of pancreatic insulinomas","volume":"60","year":"2005","journal-title":"Clin Radiol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ando.2013.05.008","article-title":"Topographic diagnosis: respective roles of morphological and functional imaging","volume":"74","year":"2013","journal-title":"Ann Endocrinol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-2005-865752","article-title":"Endoscopic ultrasound imaging of insulinomas: limitations and clinical relevance","volume":"113","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/jc.2008-1986","article-title":"Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/ERC-19-0476","article-title":"Innovative imaging of insulinoma: the end of sampling? A review","volume":"27","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/RLU.0000000000001360","article-title":"Tumor heterogeneity detected by 68Ga DOTATOC and 18F-FDG PET\/CTs in one malignant insulinoma with involvement of the portal splenic confluence and ovarian metastases","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s00330-015-3882-1","article-title":"Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET\/CT: a lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours","volume":"26","year":"2016","journal-title":"Eur Radiol"},{"key":"bib19-20250621","first-page":"69","article-title":"Somatostatin receptor based PET\/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma","volume":"60","year":"2016","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jc.2016-3445","article-title":"Localization of insulinoma using 68Ga-DOTATATE PET\/CT scan","volume":"102","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00259-016-3331-7","article-title":"Role of (68)Ga somatostatin receptor PET\/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib22-20250621","first-page":"262","article-title":"Values of 68Ga-DOTATOC and carbidopa-assisted 18F-DOPA PET\/CT for insulinoma localization","volume":"121","year":"2021","journal-title":"J Nucl Med"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.14406","article-title":"Exendin-4-based imaging in insulinoma localization: systematic review and meta-analysis","volume":"95","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2967\/jnumed.115.167445","article-title":"Glucagon-like peptide-1 receptor PET\/CT with 68Ga-NOTA-Exendin-4 for detecting localized insulinoma: a prospective cohort study","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1210\/jc.2018-02754","article-title":"68Ga-Exendin-4 PET\/CT detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1","volume":"104","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T16:03:16Z","timestamp":1750521796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004126","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}